SEC Form 4 · accession 0000950138-16-001128
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hugh M. O'Neill
Officer — Sr. VP & Pres, ARD
Period of report
May 10, 2016
Accepted (ET)
May 10, 2016 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | May 10, 2016 | P | 1,653 | $60.99 | A | 15,623 | D |
Table II — derivative securities
No Table II lines on this filing.